Sanara MedTech Inc.
SMTI
$34.73
$0.010.03%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 1.22% | 0.92% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 1.22% | 0.92% | |||
| Cost of Revenue | 3.00% | 2.62% | |||
| Gross Profit | 1.08% | 0.79% | |||
| SG&A Expenses | 3.29% | 9.00% | |||
| Depreciation & Amortization | 5.41% | -12.13% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 4.79% | 2.02% | |||
| Operating Income | -32.73% | -8.47% | |||
| Income Before Tax | -203.37% | 135.92% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -203.37% | 135.92% | |||
| Earnings from Discontinued Operations | -168.47% | 112.11% | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | 100.00% | |||
| Net Income | -198.67% | 128.51% | |||
| EBIT | -32.73% | -8.47% | |||
| EBITDA | -25.80% | -9.16% | |||
| EPS Basic | -199.24% | 127.74% | |||
| Normalized Basic EPS | -203.50% | -47.23% | |||
| EPS Diluted | -217.09% | 124.63% | |||
| Normalized Diluted EPS | -206.86% | -48.89% | |||
| Average Basic Shares Outstanding | -0.51% | 2.76% | |||
| Average Diluted Shares Outstanding | -3.60% | 6.05% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||